Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE save search
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.11%
H: 0.38%
C: -0.04%
meeting
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
Published: 2024-04-09 (Crawled : 18:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.97%
H: 0.26%
C: -0.75%
for
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.73%
H: 2.49%
C: 0.11%
abrysvo disease positive risk for rsv results study
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
Published: 2024-04-08 (Crawled : 17:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
DOW | News A | $56.745 0.45% 920K
|
Process Industries
|
| O: 0.44%
H: 0.4%
C: -0.72%
dean
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
Bluerock Value Exchange Fully Subscribes $46.5 Million Diversified Industrial Portfolio I DST
Published: 2024-03-27 (Crawled : 13:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
million
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
therapeutics
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.18%
H: 0.4%
C: -0.14%
pharmaceuticals
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Published: 2024-03-18 (Crawled : 21:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.18%
H: 0.4%
C: -0.14%
ARVN | $34.02 -0.79% 250K
|
Health Technology
|
| O: -3.22%
H: 4.58%
C: 3.23%
medical
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published: 2024-03-13 (Crawled : 11:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 1.0%
H: 1.41%
C: -0.25%
disease pneumococcal children
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Published: 2024-03-12 (Crawled : 12:30) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
adcetris positive trial
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
VERU | $1.365 -3.87% 1.7M
|
Health Technology
|
| O: -0.53%
H: 2.22%
C: -3.59%
ALT | $6.78 -1.6% 1.4M
|
Commercial Services
|
| O: 0.3%
H: 11.41%
C: 9.8%
medical program
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.22 1.67% 910K
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $17.01 -2.8% 690K
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $4.405 -2.11% 850K
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.66 -0.42% 290K
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published: 2024-03-06 (Crawled : 01:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 3.14%
H: 1.49%
C: 1.08%
KZR | $0.793 0.69% 97K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -1.9%
financial results
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - March 5, 2024
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.08%
H: 2.13%
C: 0.81%
conference
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
Published: 2024-03-04 (Crawled : 21:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -1.09%
H: 0.61%
C: -1.56%
trial
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -1.88%
abrysvo positive rsv
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
Published: 2024-02-27 (Crawled : 14:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.22%
H: 0.29%
C: -0.85%
leaders
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.22%
H: 0.29%
C: -0.85%
ARVN | $34.02 -0.79% 250K
|
Health Technology
|
| O: 0.0%
H: 1.25%
C: -1.6%
year update financial results
New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
Published: 2024-02-26 (Crawled : 00:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: -1.77%
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 4.32%
H: 7.17%
C: 2.5%
drug fibromyalgia study
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
CHRO | $1.53 24.9% 100K
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.